Central and Eastern Europe: Outsourcing Trends and Growth Opportunities in Clinical Trials

CenterWatch presents its latest report in a series on emerging markets in the clinical trials industry Central and Eastern Europe: Outsourcing Trends and Growth Opportunities in Clinical Trials. The number of clinical trials initiated in Central and Eastern Europe more than tripled from 2002 to 2007, making the region a key part of global clinical research. This comprehensive analysis focuses on the evolution of the clinical trials industry in the CEE region and the outsourcing strategies that CROs and emerging pharmaceutical and biotech companies need to operate there.

Topics include:
*Market information on 25+ countries including: Bulgaria, Czech Republic, Hungary, Poland, Romania, Russia, Turkey and Ukraine
*EU directives and other European regulatory trends
*Exclusive interviews with executives from the top CROs
*Factors driving growth
*Companies acquiring local CROs and why
*Current drug development pipeline Original and proprietary CenterWatch charts and graphs

Central and Eastern Europe is recommended for:
*Biotech and pharmaceutical companies seeking information on growth and challenges in the Central and Eastern Europe market
*Investment firms covering the life sciences industry in emerging markets
*CROs conducting business in Central and Eastern European countries